Alexandra MacLean
2023
In 2023, Alexandra MacLean earned a total compensation of $1.2M as Chief Executive Officer at AVENUE THERAPEUTICS, a 304% increase compared to previous year.
Compensation breakdown
| Option Awards | $800,000 |
|---|---|
| Salary | $400,000 |
| Other | $13,200 |
| Total | $1,213,200 |
MacLean received $800K in option awards, accounting for 66% of the total pay in 2023.
MacLean also received $400K in salary and $13.2K in other compensation.
Rankings
In 2023, Alexandra MacLean's compensation ranked 994th out of 2,907 executives tracked by ExecPay. In other words, MacLean earned more than 65.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 994 out of 2,907 | 66th |
Division Manufacturing | 597 out of 1,599 | 63rd |
Major group Chemicals And Allied Products | 410 out of 901 | 55th |
Industry group Drugs | 399 out of 864 | 54th |
Industry Pharmaceutical Preparations | 272 out of 622 | 56th |
Source: SEC filing on May 3, 2024.
MacLean's colleagues
We found one more compensation record of an executive who worked with Alexandra MacLean at AVENUE THERAPEUTICS in 2023.
2023
David Jin
AVENUE THERAPEUTICS